Notifications

Home

Stocks
- Stock Screener
- Market Movers
- Insider Trades
- Upcoming Earnings
- Upcoming Dividends
Options
- Unusual Options Activity
- Implied Volatility Rank
- Volatility %Change
News
Upcoming IPOs

Eledon Pharmaceuticals Inc (ELDN)

$1.78 +0.02 (1.14%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	113.18M
Revenue (ttm)	0.00
Net Income (ttm)	-36.18M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	2,544,521
Avg Vol	2,135,718
Day's Range	N/A - N/A
Shares Out	59.88M
Stochastic %K	10%
Beta	0.63
Analysts	Strong Sell
Price Target	$8.17

Company Profile

Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It is also developing its products for th...

Industry: Biotechnology

Sector: Healthcare

Phone: 949 238 8090

Website: eledon.com

Address:

19800 MacArthur Boulevard, Suite 250, Irvine, United States

Veraton Nov. 14 at 7:10 PM

$ELDN Next couple of PR'S will get us to 2.50-3.30 Next week we will know who bought the 15 million shares.. It can be a bullish sign depending.... Massive 🐂

0 · Reply

sethbuckner12 Nov. 14 at 6:36 PM

$ELDN shes trying to come back uo

0 · Reply

red1 Nov. 14 at 12:49 PM

$ELDN it’s buying time… let’s see that dip

0 · Reply

red1 Nov. 13 at 8:53 PM

$ELDN rediculous!

1 · Reply

ctboi Nov. 13 at 8:40 PM

$ELDN way oversold. Up.

0 · Reply

red1 Nov. 13 at 8:27 PM

$ELDN why isn’t this at 1.40 already ? I’m going to wait until Tomorrow but I wear if this goes up tomorrow I’m going to lose it!

0 · Reply

Veraton Nov. 13 at 6:56 PM

$ELDN We will have better days in the near future!!! Massive 🐂

0 · Reply

Zackpedia Nov. 13 at 4:47 PM

$ELDN You could’ve sold when I alerted and bought back at 1.6 now if you wanted, I wouldn’t

1 · Reply

red1 Nov. 13 at 3:38 PM

$ELDN come on drop some more. Hopefully big drop tomorrow adding with my pay check

0 · Reply

Aleeb Nov. 13 at 2:59 PM

$ELDN WHY would you do a stock offering right after your share price tanks. At least gaslight some positivity then do the offering. Might be time to eat the loss

0 · Reply

Eledon Pharmaceuticals Announces Pricing of $50 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

Nov 11, 2025, 5:26 PM EST - 2 days ago

Eledon Pharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

Nov 7, 2025, 2:36 PM EST - 7 days ago

Eledon Pharmaceuticals, Inc. (ELDN) Discusses Phase II BESTOW Trial Results and Advances in Transplantation Immunosuppression Transcript

Nov 7, 2025, 1:36 PM EST - 7 days ago

Eledon Pharmaceuticals' Lead Asset Fails In Mid-Stage Study, But Pushes Forward With Pivotal Study

Nov 6, 2025, 6:30 PM EST - 7 days ago

Eledon Presents Phase 2 BESTOW Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology's Kidney Week 2025 Annual Meeting

Nov 5, 2025, 7:00 AM EST - 9 days ago

Eledon Pharmaceuticals to Present at Guggenheim Second Annual Healthcare Innovation Conference

Oct 17, 2025, 7:00 AM EDT - 4 weeks ago

Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annual Meeting

Sep 24, 2025, 4:05 PM EDT - 7 weeks ago

Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association

Aug 29, 2025, 7:00 AM EDT - 2 months ago

Eledon Pharmaceuticals to Participate in Cantor Global Healthcare Conference 2025

Aug 14, 2025, 4:20 PM EDT - 3 months ago

Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial Results

Aug 6, 2025, 4:01 PM EDT - 3 months ago

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

Jul 30, 2025, 4:05 PM EDT - 3 months ago

Eledon Pharmaceuticals to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at the World Transplant Congress 2025

Jul 17, 2025, 4:01 PM EDT - 4 months ago

Updated Data from Eledon Pharmaceuticals' Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025

Jun 25, 2025, 4:01 PM EDT - 5 months ago

Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City

May 14, 2025, 4:01 PM EDT - 6 months ago

Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results

May 6, 2025, 1:15 PM EDT - 6 months ago

Undercovered Dozen: Gevo, Eledon, Dorian, Iridium +

GEVO IRDM LPG

May 3, 2025, 8:15 AM EDT - 6 months ago

Eledon: A Company With Good Early Data In Kidney Transplant Rejection And A Full Balance Sheet

Mar 20, 2025, 4:01 PM EDT - 8 months ago

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results

Mar 4, 2025, 4:05 PM EST - 9 months ago

Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference

Feb 7, 2025, 10:00 AM EST - 10 months ago

Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human

Jan 29, 2025, 4:05 PM EST - 10 months ago

Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference

Jan 28, 2025, 11:27 AM EST - 10 months ago

Eledon Pharmaceuticals: At The Forefront Of The Organ Transplant Management Business

Jan 13, 2025, 7:00 AM EST - 10 months ago

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook

Nov 12, 2024, 4:01 PM EST - 1 year ago

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results

Oct 29, 2024, 3:51 PM EDT - 1 year ago

Eledon: Changing Scope Of Immunosuppressive Drug Space With Tegoprubart

Oct 29, 2024, 7:46 AM EDT - 1 year ago

Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Oct 29, 2024, 7:45 AM EDT - 1 year ago

Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine

Sep 11, 2024, 4:05 PM EDT - 1 year ago

Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference

Sep 4, 2024, 7:00 AM EDT - 1 year ago

Eledon Announces Completion of Enrollment in Phase 2 BESTOW Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients

Aug 14, 2024, 5:21 PM EDT - 1 year ago

Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results

Jul 29, 2024, 7:00 AM EDT - 1 year ago

Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection

Jul 2, 2024, 4:05 PM EDT - 1 year ago

Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism

May 9, 2024, 7:30 AM EDT - 1 year ago

Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results

May 9, 2024, 7:00 AM EDT - 1 year ago

Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress

May 7, 2024, 7:05 AM EDT - 1 year ago

Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection

Mar 28, 2024, 4:01 PM EDT - 1 year ago

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results

Mar 25, 2024, 4:56 PM EDT - 1 year ago

Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection

Mar 21, 2024, 10:31 AM EDT - 1 year ago

Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human

Feb 13, 2024, 7:01 PM EST - 1 year ago

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jan 4, 2024, 4:40 PM EST - 2 years ago

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook

Nov 29, 2023, 4:05 PM EST - 2 years ago

Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference

Nov 9, 2023, 4:01 PM EST - 2 years ago

Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results

Nov 8, 2023, 4:05 PM EST - 2 years ago

Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference

Nov 2, 2023, 9:05 AM EDT - 2 years ago

Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

Oct 23, 2023, 7:00 AM EDT - 2 years ago

Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer

Oct 13, 2023, 7:00 AM EDT - 2 years ago

Eledon Pharmaceuticals to Present Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Society of Nephrology Kidney Week 2023 Annual Meeting

Oct 2, 2023, 7:00 AM EDT - 2 years ago

Eledon Pharmaceuticals Appoints Kidney Transplant Specialist Dr. Allan Douglas Kirk to Board of Directors

Sep 25, 2023, 7:00 AM EDT - 2 years ago

Eledon Pharmaceuticals Announces Use of Tegoprubart anti-CD40L Antibody in Second-ever Transplant of Genetically Modified Heart from a Pig to a Human

Sep 20, 2023, 4:05 PM EDT - 2 years ago

Eledon Pharmaceuticals to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference

Sep 11, 2023, 7:00 AM EDT - 2 years ago

Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors

Veraton Nov. 14 at 7:10 PM

$ELDN Next couple of PR'S will get us to 2.50-3.30 Next week we will know who bought the 15 million shares.. It can be a bullish sign depending.... Massive 🐂

0 · Reply

sethbuckner12 Nov. 14 at 6:36 PM

$ELDN shes trying to come back uo

0 · Reply

red1 Nov. 14 at 12:49 PM

$ELDN it’s buying time… let’s see that dip

0 · Reply

red1 Nov. 13 at 8:53 PM

$ELDN rediculous!

1 · Reply

ctboi Nov. 13 at 8:40 PM

$ELDN way oversold. Up.

0 · Reply

red1 Nov. 13 at 8:27 PM

$ELDN why isn’t this at 1.40 already ? I’m going to wait until Tomorrow but I wear if this goes up tomorrow I’m going to lose it!

0 · Reply

Veraton Nov. 13 at 6:56 PM

$ELDN We will have better days in the near future!!! Massive 🐂

0 · Reply

Zackpedia Nov. 13 at 4:47 PM

$ELDN You could’ve sold when I alerted and bought back at 1.6 now if you wanted, I wouldn’t

1 · Reply

red1 Nov. 13 at 3:38 PM

$ELDN come on drop some more. Hopefully big drop tomorrow adding with my pay check

0 · Reply

Aleeb Nov. 13 at 2:59 PM

$ELDN WHY would you do a stock offering right after your share price tanks. At least gaslight some positivity then do the offering. Might be time to eat the loss

0 · Reply

red1 Nov. 13 at 2:40 PM

$ELDN added

0 · Reply

Veraton Nov. 13 at 1:11 PM

$ELDN Sanofi acquire Provention Bio for $25.00 per share in cash, representing an equity value of $2.9 billion. March 13, 2023.

1 · Reply

red1 Nov. 13 at 1:06 PM

$ELDN clearly ppl didn’t understand the data… the drug is safe and effective will be worth 6b + just a matter of when . I’m buying every pay check no matter the price. Have a good day !

0 · Reply

Veraton Nov. 13 at 12:59 PM

$ELDN In want to blow some steem with you guys... I just talked to a friend MD... And ask him a simple question... When Sanofi BO provention 2 years ago for 2.9 billion,,, their drug teplizumab in any aspect was near in efficacy and safety where tego is right now.... Just saying But again just wondering... Where's 🐂😘

0 · Reply

Veraton Nov. 13 at 12:45 PM

$ELDN Easy I'm buying whatever i can today between 1.75-1.95

0 · Reply

red1 Nov. 13 at 12:38 PM

$ELDN please elaborate

0 · Reply

Veraton Nov. 13 at 12:06 PM

$ELDN Today EDGAR/SEC

0 · Reply

Veraton Nov. 13 at 11:06 AM

$ELDN Doubling ♦️ ♠️ 🐂

0 · Reply

Zackpedia Nov. 12 at 8:52 PM

$ELDN Selling time at 1.93

0 · Reply

Theflash88 Nov. 12 at 6:45 PM

$ELDN Ouch

0 · Reply

red1 Nov. 12 at 5:44 PM

$ELDN added some more

0 · Reply

Zigmasterflex Nov. 12 at 5:14 PM

$ELDN why didnt they do the offering a few weeks ago when it was in the 3s. they would have made more money

2 · Reply

1.0.0